Survival Rates for Patients with End-stage Renal Disease Receiving Renal Replacement Therapy at Yang Talat Hospital, Kalasin Province, Thailand

Abstract

Background and Objective:   Numbers of patients with end-stage renal disease  are  increasing , especially in Kalasin Province. This study  analyzed patient data from Health Information System to compare survival rates  of end-stage renal failure patients receiving renal replacement therapy  at Yang Talat Hospital.

Method: This  was a  retrospective cohort study using   the chronic renal failure  medical record database at Yang Talat Hospital's hemodialysis clinic, for patients registered between  August 1^st, 2010 and December 31^st, 2017.  All 196 patients were then followed up  until 31^st December 2020. Survival rates were  analyzed by the Kaplan-Meier method. The log-rank test was used to compare survival distributions between groups. Multivariate  analysis was conducted using a Cox regression.

Result: After adjusting for  co-morbidity  of serum albumin and  peritonitis, we found  end-stage renal failure patients receiving continuous ambulatory peritoneal dialysis renal replacement therapy had 1.93 times  risk of death compared with end-stage renal failure patients who received renal replacement therapy by hemodialysis. (Adjusted HR = 1.93; 95% confidence interval; 1.09 - 3.39; p=0.021).The survival rates at 1, 3 and 5 years of end-stage renal failure patients who received renal replacement therapy by hemodialysis were  92.7%, 82.7% , and 68.7%, and by peritoneal dialysis were 88.6% , 63.4%, and 47.8% respectively.

Conclusion: Survival rates for patients receiving  renal replacement therapy by hemodialysis were higher than those  receiving  renal replacement therapy by peritoneal dialysis.